19962019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Simon Spazzapan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 55 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial

BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

  • Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

    members of the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 2, p. 105-114 10 p.

    Research output: Contribution to journalArticle

  • Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

    Ruhstaller, T., Giobbie-Hurder, A., Colleoni, M., Jensen, M-B., Ejlertsen, B., de Azambuja, E., Neven, P., Láng, I., Jakobsen, E. H., Gladieff, L., Bonnefoi, H., Harvey, V. J., Spazzapan, S., Tondini, C., Del Mastro, L., Veyret, C., Simoncini, E., Gianni, L., Rochlitz, C., Kralidis, E. & 10 others, Zaman, K., Jassem, J., Piccart-Gebhart, M., Di Leo, A., Gelber, R. D., Coates, A. S., Goldhirsch, A., Thürlimann, B., Regan, M. M. & Group, M. O. T. BIG. . C. G. A. T. I. B. C. S., Jan 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 2, p. 105-114 10 p.

    Research output: Contribution to journalArticle

  • Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

    Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, P., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jun 2019, In : Oncologist. 24, 6, p. e232-e240

    Research output: Contribution to journalArticle

    Open Access
  • Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation

    Pelizzari, G., Gerratana, L., Basile, D., Fanotto, V., Bartoletti, M., Liguori, A., Fontanella, C., Spazzapan, S. & Puglisi, F., Jan 1 2019, In : Cancer Treatment Reviews. 72, p. 7-14 8 p.

    Research output: Contribution to journalReview article